t
AIB Group plc announced it purchased a total of 2,432,635 of its ordinary shares on Euronext Dublin through Goodbody Stockbrokers UC from 27 April 2026 to 30 April 2026. These purchases are part of the Company's €1.0 billion share buyback programme, announced on 4 March 2026, and the repurchased shares will be cancelled. Following cancellation, the Company's total number of ordinary shares in issue will be 2,114,706,542.
| Date | 5 May 2026 |
| Time | 11:07:28 |
| Category | Capital structure |
| ID | 0715D |
05 May 2026
AIB Group plc
Transaction in Own Shares
AIB Group plc ("AIB" or the "Company") announces that from 27 April 2026 to 30 April 2026, it purchased a total of 2,432,635 of its ordinary shares of EUR 0.625 each ("Ordinary Shares") on Euronext Dublin through Goodbody Stockbrokers UC ("Goodbody"), as detailed below. The purchases form part of the Company's €1.0 billion share buyback programme announced on 4 March 2026. The repurchased shares will be cancelled.
|
Date of purchase |
Number of ordinary shares purchased |
Highest price paid (per ordinary share) |
Lowest price paid (per ordinary share) |
Volume weighted average price paid (per ordinary share) |
|
27 April 2026 |
850,000 |
9.48 |
9.34 |
9.3873 |
|
28 April 2026 |
507,635 |
9.65 |
9.50 |
9.5874 |
|
29 April 2026 |
475,000 |
9.80 |
9.65 |
9.7359 |
|
30 April 2026 |
600,000 |
9.79 |
9.54 |
9.6995 |
Following cancellation of the repurchased shares above, the Company's total number of Ordinary Shares in issue shall be 2,114,706,542, each carrying the right to one vote. The Company holds nil Ordinary Shares in treasury.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades made by Goodbody on behalf of the Company as part of the share buyback programme can be found at:
http://www.rns-pdf.londonstockexchange.com/rns/0715D_1-2026-5-5.pdf
For further information, please contact:
|
Niamh Hore / Siobhain Walsh Investor Relations AIB Group plc Dublin Tel: +353-86-3135647 / +353-87-3956864 |
|